We’re lifting our price target on Cardinal Health after issuing rosy profit guidance
Cardinal Health on Tuesday showed why the healthcare distributor belongs in our portfolio, delivering robust full-year earnings guidance…
We’re increasing our Eli Lilly price target after another beat-and-raise quarter
Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…
We’re raising our Meta price target big time after a stellar quarter and an incredible guide
Meta Platforms shares soared Wednesday evening after the social media juggernaut delivered what can only be described as…
The market is getting Dover’s earnings all wrong. Here’s what the sellers are missing
Dover shares fell Thursday despite reporting better-than-expected second quarter results and raising its full-year outlook. We think the market…